{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:57:46Z","timestamp":1788904666309,"version":"build-2803163510"},"reference-count":304,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008867","name":"Department of Education of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ajps.2026.101144","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:33:52Z","timestamp":1774370032000},"page":"101144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in nanotechnology for the diagnosis and management of autoimmune diseases"],"prefix":"10.1016","volume":"21","author":[{"given":"Yongquan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4560-6861","authenticated-orcid":false,"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajps.2026.101144_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ajps.2026.101144_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1482728","article-title":"Autoimmune disease: a view of epigenetics and therapeutic targeting","volume":"15","author":"Mu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2026.101144_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103088","article-title":"Clinical utility of measuring CD4+ T follicular cells in patients with immune dysregulation","volume":"140","author":"LaBere","year":"2023","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.ajps.2026.101144_bib0004","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s00210-023-02514-5","article-title":"Advancement in nanotechnology for treatment of rheumatoid arthritis: scope and potential applications","volume":"396","author":"Rani","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/brainsci10060338","article-title":"Promising nanotechnology approaches in treatment of autoimmune diseases of central nervous system","volume":"10","author":"Chountoulesi","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.ajps.2026.101144_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101694","article-title":"Recent advances of nanotechnology application in autoimmune diseases-a bibliometric analysis","volume":"48","author":"He","year":"2023","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0007","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jfb16010024","article-title":"Biodegradable and stimuli-responsive nanomaterials for targeted drug delivery in autoimmune diseases","volume":"16","author":"Parvin","year":"2025","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.ajps.2026.101144_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115194","article-title":"Emerging strategies for nanomedicine in autoimmunity","volume":"207","author":"Thatte","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.ajps.2026.101144_bib0009","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1021\/acssensors.3c00633","article-title":"Single-walled carbon nanotube sensor selection for the detection of MicroRNA biomarkers for acute myocardial infarction as a case study","volume":"8","author":"Hendler-Neumark","year":"2023","journal-title":"ACS Sens"},{"issue":"15","key":"10.1016\/j.ajps.2026.101144_bib0010","article-title":"Biomimetic nanoplatform for targeted rheumatoid arthritis therapy: modulating macrophage niches through self-sustaining positive feedback-driven drug release mechanisms","volume":"12","author":"Xie","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.ajps.2026.101144_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116164","article-title":"Effective enrichment of trace exosomes for the label-free SERS detection via low-cost thermophoretic profiling","volume":"253","author":"Guo","year":"2024","journal-title":"Biosens Bioelectron"},{"issue":"13","key":"10.1016\/j.ajps.2026.101144_bib0012","doi-asserted-by":"crossref","first-page":"12052","DOI":"10.1021\/acsnano.2c09222","article-title":"MoS2-plasmonic nanocavities for raman spectra of single extracellular vesicles reveal molecular progression in glioblastoma","volume":"17","author":"Jalali","year":"2023","journal-title":"ACS Nano"},{"issue":"22","key":"10.1016\/j.ajps.2026.101144_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202500113","article-title":"Inflammation targeting and responsive multifunctional drug-delivery nanoplatforms for combined therapy of rheumatoid arthritis","volume":"21","author":"Li","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.ajps.2026.101144_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113898","article-title":"Evolution of nanomedicines for the treatment of autoimmune disease: from vehicles for drug delivery to inducers of bystander immunoregulation","volume":"176","author":"Yang","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"26","key":"10.1016\/j.ajps.2026.101144_bib0015","doi-asserted-by":"crossref","first-page":"33106","DOI":"10.1021\/acsami.4c05428","article-title":"Administration of ROS-scavenging cerium oxide nanoparticles simply mixed with autoantigenic peptides induce antigen-specific immune tolerance against autoimmune encephalomyelitis","volume":"16","author":"Nguyen","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6525","key":"10.1016\/j.ajps.2026.101144_bib0016","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0017","first-page":"5219","article-title":"Tolerogenic nano-\/microparticle vaccines for immunotherapy","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101144_bib0018","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.copbio.2021.12.012","article-title":"Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomes","volume":"74","author":"Yang","year":"2022","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101566","article-title":"Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases","volume":"33","author":"Razavi","year":"2025","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0020","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/s12951-025-03766-4","article-title":"Nanomedicine targeting the PD-1\/PD-L1 axis in autoimmune diseases: breaking conventional barriers to restore immune tolerance","volume":"23","author":"Xiang","year":"2025","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0021","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12951-024-02901-x","article-title":"Nanotechnology in healthcare, and its safety and environmental risks","volume":"22","author":"Ma","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.ajps.2026.101144_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120807","article-title":"PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up","volume":"605","author":"Operti","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2026.101144_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125202","article-title":"Navigating translational research in nanomedicine: a strategic guide to formulation and manufacturing","volume":"671","author":"Zhang","year":"2025","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0024","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/antiox11061153","article-title":"The role of reactive oxygen species in the rheumatoid arthritis-associated synovial microenvironment","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0025","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/acr2.11073","article-title":"Type I interferon predicts an alternate immune system phenotype in systemic lupus erythematosus","volume":"1","author":"Thanarajasingam","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.ajps.2026.101144_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1457213","article-title":"Fifty years of HLA-associated type 1 diabetes risk: history, current knowledge, and future directions","volume":"15","author":"Noble","year":"2024","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ajps.2026.101144_bib0027","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","author":"Collaborators","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0028","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajps.2026.101144_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1073278","article-title":"Global, regional, and national burden of multiple sclerosis from 1990 to 2019: findings of global burden of disease study 2019","volume":"11","author":"Qian","year":"2023","journal-title":"Front Public Health"},{"issue":"8067","key":"10.1016\/j.ajps.2026.101144_bib0030","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","article-title":"Global evolution of inflammatory bowel disease across epidemiologic stages","volume":"642","author":"Hracs","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ajps.2026.101144_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1339714","article-title":"Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis","volume":"15","author":"Shirafkan","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2026.101144_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1468469","article-title":"Subpopulation dynamics of T and B lymphocytes in Sjogren\u2019s syndrome: implications for disease activity and treatment","volume":"15","author":"Meng","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0033","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4110\/in.2024.24.e8","article-title":"Cytokines in follicular helper T cell biology in physiologic and pathologic conditions","volume":"24","author":"Choi","year":"2024","journal-title":"Immune Netw"},{"key":"10.1016\/j.ajps.2026.101144_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103046","article-title":"Impact of protein coronas on nanoparticle interactions with tissues and targeted delivery","volume":"85","author":"Chou","year":"2024","journal-title":"Curr Opin Biotechnol"},{"issue":"5","key":"10.1016\/j.ajps.2026.101144_bib0035","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1002\/mco2.549","article-title":"Toll-like receptors in health and disease","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm (2020)"},{"issue":"9","key":"10.1016\/j.ajps.2026.101144_bib0036","first-page":"1541","article-title":"Interaction of HLA-DRB1 shared epitope and smoking on the development of anti-citrullinated protein antibody positive rheumatoid arthritis in Greek patients","volume":"43","author":"Mole","year":"2025","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0037","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/microorganisms12071387","article-title":"Exploring the role of the microbiome in rheumatoid arthritis-a critical review","volume":"12","author":"Ermencheva","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ajps.2026.101144_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105837","article-title":"Inflammation-modulating polymeric nanoparticles: design strategies, mechanisms, and therapeutic applications","volume":"118","author":"Zhang","year":"2025","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0039","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12964-023-01466-w","article-title":"cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun Signal"},{"issue":"9","key":"10.1016\/j.ajps.2026.101144_bib0040","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"3 Pt B","key":"10.1016\/j.ajps.2026.101144_bib0041","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jid.2021.11.031","article-title":"Type I interferons in autoimmunity","volume":"142","author":"Fernandez-Ruiz","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0042","doi-asserted-by":"crossref","first-page":"431","DOI":"10.21037\/atm-21-4533","article-title":"cGAS\/STING signaling in the regulation of rheumatoid synovial aggression","volume":"10","author":"Li","year":"2022","journal-title":"Ann Transl Med"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0043","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41590-023-01527-9","article-title":"Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis","volume":"24","author":"Smith","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajps.2026.101144_bib0044","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers","volume":"11","author":"van Langelaar","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ajps.2026.101144_bib0045","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1007\/s10620-023-08122-w","article-title":"Intestinal barrier dysfunction in inflammatory bowel disease: underpinning pathogenesis and therapeutics","volume":"68","author":"Dunleavy","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajps.2026.101144_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.868343","article-title":"Trained immunity contribution to autoimmune and inflammatory disorders","volume":"13","author":"Funes","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0047","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","article-title":"The interferon signature in autoimmune diseases","volume":"25","author":"Ronnblom","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ajps.2026.101144_bib0048","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0049","first-page":"4867","article-title":"Indoleamine 2, 3-dioxygenase regulation of immune response (review)","volume":"17","author":"Wu","year":"2018","journal-title":"Mol Med Rep"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/intimm\/dxt011","article-title":"The roles of aryl hydrocarbon receptor in immune responses","volume":"25","author":"Nguyen","year":"2013","journal-title":"Int Immunol"},{"key":"10.1016\/j.ajps.2026.101144_bib0051","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ajps.2026.101144_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102283","article-title":"Immune checkpoint receptors in autoimmunity","volume":"80","author":"Burke","year":"2023","journal-title":"Curr Opin Immunol"},{"issue":"5 Suppl 31","key":"10.1016\/j.ajps.2026.101144_bib0053","first-page":"S154","article-title":"Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention","volume":"21","author":"Quinn","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ajps.2026.101144_bib0054","first-page":"1","article-title":"Early rheumatoid arthritis\u2014is there a window of opportunity?","volume":"80","author":"Cush","year":"2007","journal-title":"J Rheumatol Suppl"},{"issue":"10416","key":"10.1016\/j.ajps.2026.101144_bib0055","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0056","first-page":"554","article-title":"Seronegative rheumatoid arthritis: one year in review 2023","volume":"41","author":"De Stefano","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0057","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/annrheumdis-2015-208873","article-title":"Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naive patients classified according to the 2010 ACR\/EULAR criteria","volume":"76","author":"Nordberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajps.2026.101144_bib0058","article-title":"Patients with seronegative rheumatoid arthritis have a different phenotype than seropositive patients: a clinical and ultrasound study","volume":"9","author":"Carbonell-Bobadilla","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0059","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/jcm8010015","article-title":"Risk of infection with methotrexate therapy in inflammatory diseases: a systematic review and meta-analysis","volume":"8","author":"Ibrahim","year":"2018","journal-title":"J Clin Med"},{"issue":"9990","key":"10.1016\/j.ajps.2026.101144_bib0060","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)61704-9","article-title":"Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"386","author":"Singh","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0061","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/BOR.0000000000000598","article-title":"Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?","volume":"31","author":"Jani","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.ajps.2026.101144_bib0062","first-page":"1781","article-title":"Uncovering risk factors for adverse events and infections in rheumatoid arthritis and rheumatoid arthritis with interstitial lung disease under treatment with biologics or targeted synthetic DMARDs: insights from the KOBIO Registry","volume":"42","author":"Kim","year":"2024","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.ajps.2026.101144_bib0063","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.20151876","article-title":"Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus","volume":"213","author":"Caielli","year":"2016","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0064","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"issue":"Suppl 2","key":"10.1016\/j.ajps.2026.101144_bib0065","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.33549\/physiolres.933977","article-title":"Polymer-drug conjugates in inflammation treatment","volume":"67","author":"Koziolova","year":"2018","journal-title":"Physiol Res"},{"key":"10.1016\/j.ajps.2026.101144_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.819163","article-title":"Folate receptor beta for macrophage imaging in rheumatoid arthritis","volume":"13","author":"Steinz","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2026.101144_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119730","article-title":"Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2\/TNF-alpha\/BAFF signaling pathway","volume":"232","author":"Ni","year":"2020","journal-title":"Biomaterials"},{"issue":"26","key":"10.1016\/j.ajps.2026.101144_bib0068","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300962","article-title":"An MMP-2 responsive nanotheranostic probe enabled synergistic therapy of rheumatoid arthritis and MR\/CT assessment of therapeutic response in situ","volume":"12","author":"Chen","year":"2023","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0069","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1073\/pnas.1408686111","article-title":"Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance","volume":"112","author":"Maldonado","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7493","key":"10.1016\/j.ajps.2026.101144_bib0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature12978","article-title":"Structure-based programming of lymph-node targeting in molecular vaccines","volume":"507","author":"Liu","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0071","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.nano.2014.12.003","article-title":"Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction","volume":"11","author":"Gharagozloo","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ajps.2026.101144_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213126","article-title":"ROS responsive polydopamine nanoparticles to relieve oxidative stress and inflammation for ameliorating acute inflammatory bowel","volume":"142","author":"Yan","year":"2022","journal-title":"Biomater Adv"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0073","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1182\/blood-2008-04-150789","article-title":"A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages","volume":"113","author":"Xia","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0074","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/10717544.2018.1447050","article-title":"Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy","volume":"25","author":"Zhou","year":"2018","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s11671-023-03882-w","article-title":"Effect of nanoparticle size on their distribution and retention in chronic inflammation sites","volume":"18","author":"Aldayel","year":"2023","journal-title":"Discov Nano"},{"key":"10.1016\/j.ajps.2026.101144_bib0076","article-title":"Nanoparticle-induced complement activation: implications for cancer nanomedicine","volume":"11","author":"La-Beck","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0077","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajps.2026.101144_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105240","article-title":"Current trends in theranostics for rheumatoid arthritis","volume":"145","author":"Madav","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0079","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12951-020-00666-7","article-title":"MMP-13 enzyme and pH responsive theranostic nanoplatform for osteoarthritis","volume":"18","author":"Lan","year":"2020","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/acscentsci.6b00190","article-title":"Does nanomedicine have a delivery problem?","volume":"2","author":"Torrice","year":"2016","journal-title":"ACS Cent Sci"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0081","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1021\/acsnano.9b08142","article-title":"Meta-analysis of nanoparticle delivery to tumors using a physiologically based pharmacokinetic modeling and simulation approach","volume":"14","author":"Cheng","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101144_bib0082","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addr.2019.05.010","article-title":"Ligand density on nanoparticles: a parameter with critical impact on nanomedicine","volume":"143","author":"Alkilany","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0083","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nano.2012.05.015","article-title":"Effect of ligand density, receptor density, and nanoparticle size on cell targeting","volume":"9","author":"Elias","year":"2013","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0084","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/jps.22342","article-title":"Controlling ligand surface density optimizes nanoparticle binding to ICAM-1","volume":"100","author":"Fakhari","year":"2011","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0086","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1038\/s41467-022-35278-2","article-title":"Ultrasensitive rapid cytokine sensors based on asymmetric geometry two-dimensional MoS2 diodes","volume":"13","author":"De Silva","year":"2022","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.ajps.2026.101144_bib0087","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.3390\/s20216289","article-title":"Optical biosensors for the detection of rheumatoid arthritis (RA) biomarkers: a comprehensive review","volume":"20","author":"Imas","year":"2020","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.ajps.2026.101144_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119767","article-title":"Anti-CCP biosensors in rheumatoid arthritis","volume":"561","author":"Karami","year":"2024","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.ajps.2026.101144_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103479","article-title":"Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus \u2013 a proposal from an expert panel","volume":"22","author":"Rojo","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0090","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3390\/nano10081503","article-title":"A wearable and deformable graphene-based affinity nanosensor for monitoring of cytokines in biofluids","volume":"10","author":"Wang","year":"2020","journal-title":"Nanomaterials (Basel)"},{"issue":"14","key":"10.1016\/j.ajps.2026.101144_bib0091","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1039\/D3LC00210A","article-title":"Continuous molecular monitoring of human dermal interstitial fluid with microneedle-enabled electrochemical aptamer sensors","volume":"23","author":"Friedel","year":"2023","journal-title":"Lab Chip"},{"issue":"24","key":"10.1016\/j.ajps.2026.101144_bib0092","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.3390\/s21248491","article-title":"Recent advances in aptasensor for cytokine detection: a review","volume":"21","author":"Kim","year":"2021","journal-title":"Sensors (Basel)"},{"issue":"5","key":"10.1016\/j.ajps.2026.101144_bib0093","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3390\/s24051510","article-title":"Recent advances in biosensors for diagnosis of autoimmune diseases","volume":"24","author":"Teniou","year":"2024","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.ajps.2026.101144_bib0094","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actbio.2016.04.023","article-title":"Ultra-low fouling and high antibody loading zwitterionic hydrogel coatings for sensing and detection in complex media","volume":"40","author":"Chou","year":"2016","journal-title":"Acta Biomater"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0095","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1021\/acs.chemrev.9b00739","article-title":"Antifouling strategies for selective in vitro and in vivo sensing","volume":"120","author":"Jiang","year":"2020","journal-title":"Chem Rev"},{"issue":"29","key":"10.1016\/j.ajps.2026.101144_bib0096","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1039\/D4AY00789A","article-title":"Early diagnosis of autoimmune diseases through electrochemical biosensing using a modified plastic chip electrode","volume":"16","author":"Patel","year":"2024","journal-title":"Anal Methods"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0097","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10220","article-title":"Temporal profiling of cytokines in passively expressed sweat for detection of infection using wearable device","volume":"6","author":"Jagannath","year":"2021","journal-title":"Bioeng Transl Med"},{"issue":"31","key":"10.1016\/j.ajps.2026.101144_bib0098","doi-asserted-by":"crossref","first-page":"20422","DOI":"10.1021\/acsomega.1c02414","article-title":"Tuning SLOCK toward chronic disease diagnostics and management: label-free sweat interleukin-31 detection","volume":"6","author":"Upasham","year":"2021","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0099","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiol.2331031402","article-title":"Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging","volume":"233","author":"Lutz","year":"2004","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.ajps.2026.101144_bib0100","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0730-725X(01)00448-9","article-title":"MR imaging of murine arthritis using ultrasmall superparamagnetic iron oxide particles","volume":"19","author":"Dardzinski","year":"2001","journal-title":"Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0101","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jmri.20667","article-title":"USPIO-enhanced MR imaging for visualization of synovial hyperperfusion and detection of synovial macrophages: preliminary results in an experimental model of antigen-induced arthritis","volume":"24","author":"Lutz","year":"2006","journal-title":"J Magn Reson Imaging"},{"issue":"12","key":"10.1016\/j.ajps.2026.101144_bib0102","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2217\/nnm.12.198","article-title":"Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI","volume":"8","author":"Khurana","year":"2013","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0103","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-9255-9-24","article-title":"Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI)","volume":"9","author":"Balducci","year":"2012","journal-title":"J Inflamm (Lond)"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50043-0","article-title":"Imaging rheumatoid arthritis in mice using combined near infrared and 19F magnetic resonance modalities","volume":"9","author":"Vu-Quang","year":"2019","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ajps.2026.101144_bib0105","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2967\/jnumed.119.241356","article-title":"Folate receptor beta-targeted PET imaging of macrophages in autoimmune myocarditis","volume":"61","author":"Jahandideh","year":"2020","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70394-3","article-title":"Radiosynthesis and preclinical evaluation of [68Ga]Ga-NOTA-folate for PET imaging of folate receptor beta-positive macrophages","volume":"10","author":"Moisio","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0107","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15147-5","article-title":"A functional study of human inflammatory arthritis using photoacoustic imaging","volume":"7","author":"Jo","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0108","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/cells8080773","article-title":"An exosomal urinary miRNA signature for early diagnosis of renal fibrosis in lupus nephritis","volume":"8","author":"Sole","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0109","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/ijms21041372","article-title":"The urinary exosomal miRNA expression profile is predictive of clinical response in lupus nephritis","volume":"21","author":"Garcia-Vives","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101144_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2020.100042","article-title":"Urinary biomarkers in lupus nephritis","volume":"3","author":"Aragon","year":"2020","journal-title":"J Transl Autoimmun"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0111","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000631","article-title":"Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosus","volume":"9","author":"Aljaberi","year":"2022","journal-title":"Lupus Sci Med"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0112","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s00467-023-05888-z","article-title":"Urine biomarker score captures response to induction therapy with lupus nephritis","volume":"38","author":"Cody","year":"2023","journal-title":"Pediatr Nephrol"},{"issue":"16","key":"10.1016\/j.ajps.2026.101144_bib0113","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1039\/C6LC00279J","article-title":"Ultrasensitive microfluidic analysis of circulating exosomes using a nanostructured graphene oxide\/polydopamine coating","volume":"16","author":"Zhang","year":"2016","journal-title":"Lab Chip"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0114","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1039\/C5LC01117E","article-title":"A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis","volume":"16","author":"Zhao","year":"2016","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12951-020-00613-6","article-title":"Application of magnetic nanoparticles in nucleic acid detection","volume":"18","author":"Tang","year":"2020","journal-title":"J Nanobiotechnol."},{"key":"10.1016\/j.ajps.2026.101144_bib0116","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fimmu.2019.00502","article-title":"Cell-free DNA as a biomarker in autoimmune rheumatic diseases","volume":"10","author":"Duvvuri","year":"2019","journal-title":"Front Immunol"},{"issue":"6538","key":"10.1016\/j.ajps.2026.101144_bib0117","doi-asserted-by":"crossref","first-page":"eaaw3616","DOI":"10.1126\/science.aaw3616","article-title":"Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies","volume":"372","author":"Lo","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ajps.2026.101144_bib0118","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fnins.2017.00278","article-title":"Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes","volume":"11","author":"Mustapic","year":"2017","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0119","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/bios12040257","article-title":"Target-specific exosome isolation through aptamer-based microfluidics","volume":"12","author":"Zhou","year":"2022","journal-title":"Biosensors (Basel)"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/bios13010050","article-title":"Microfluidic strategies for extracellular vesicle isolation: towards clinical applications","volume":"13","author":"Meggiolaro","year":"2022","journal-title":"Biosensors (Basel)"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0121","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12967-020-02609-0","article-title":"Extracellular vesicles as potential biomarkers and therapeutic approaches in autoimmune diseases","volume":"18","author":"Xu","year":"2020","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0122","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41551-020-00672-y","article-title":"Microneedle patch for the ultrasensitive quantification of protein biomarkers in interstitial fluid","volume":"5","author":"Wang","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.ajps.2026.101144_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115301","article-title":"A wearable electrochemical fabric for cytokine monitoring","volume":"232","author":"Chu","year":"2023","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0124","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/s41598-024-53522-1","article-title":"Longitudinal assessment of sweat-based TNF-alpha in inflammatory bowel disease using a wearable device","volume":"14","author":"Hirten","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/bios14020098","article-title":"Duplex vertical-flow rapid tests for point-of-care detection of anti-dsDNA and anti-nuclear autoantibodies","volume":"14","author":"Lei","year":"2024","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.ajps.2026.101144_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2024.113745","article-title":"Smartphone based lateral flow immunoassay quantifications","volume":"533","author":"Park","year":"2024","journal-title":"J Immunol Methods"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0127","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41587-019-0040-3","article-title":"Accessing analytes in biofluids for peripheral biochemical monitoring","volume":"37","author":"Heikenfeld","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-anchem-061318-114910","article-title":"Wearable sensors for biochemical sweat analysis","volume":"12","author":"Bandodkar","year":"2019","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"issue":"11","key":"10.1016\/j.ajps.2026.101144_bib0129","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41551-022-00887-1","article-title":"An integrated wearable microneedle array for the continuous monitoring of multiple biomarkers in interstitial fluid","volume":"6","author":"Tehrani","year":"2022","journal-title":"Nat Biomed Eng"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41587-019-0045-y","article-title":"Wearable biosensors for healthcare monitoring","volume":"37","author":"Kim","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"12","key":"10.1016\/j.ajps.2026.101144_bib0131","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41551-022-00998-9","article-title":"Opportunities and challenges in the diagnostic utility of dermal interstitial fluid","volume":"7","author":"Friedel","year":"2023","journal-title":"Nat Biomed Eng"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0132","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41587-023-02059-1","article-title":"The challenges and promise of sweat sensing","volume":"42","author":"Davis","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"36","key":"10.1016\/j.ajps.2026.101144_bib0133","doi-asserted-by":"crossref","first-page":"24605","DOI":"10.1021\/acsnano.4c10344","article-title":"Diving into sweat: advances, challenges, and future directions in wearable sweat sensing","volume":"18","author":"Childs","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101144_bib0134","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2024.124592","article-title":"Non-invasive detection of systemic lupus erythematosus using SERS serum detection technology and deep learning algorithms","volume":"320","author":"Wang","year":"2024","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"10","key":"10.1016\/j.ajps.2026.101144_bib0135","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1007\/s00415-024-12651-3","article-title":"Predicting multiple sclerosis disease progression and outcomes with machine learning and MRI-based biomarkers: a review","volume":"271","author":"Yousef","year":"2024","journal-title":"J Neurol"},{"issue":"18","key":"10.1016\/j.ajps.2026.101144_bib0136","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202500264","article-title":"AI-assisted plasmonic diagnostics platform for osteoarthritis and rheumatoid arthritis with biomarker quantification using mathematical models","volume":"21","author":"Heo","year":"2025","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0137","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-59850-6","article-title":"Raman hyperspectroscopy of saliva and machine learning for Sjogren\u2019s disease diagnostics","volume":"14","author":"Vyas","year":"2024","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0138","article-title":"Concepts and applications of digital twins in healthcare and medicine","volume":"5","author":"Zhang","year":"2024","journal-title":"Patterns (NY)"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0139","article-title":"The role of blockchain to secure internet of medical things","volume":"14","author":"Ghadi","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12911-020-01332-6","article-title":"Explainability for artificial intelligence in healthcare: a multidisciplinary perspective","volume":"20","author":"Amann","year":"2020","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.ajps.2026.101144_bib0141","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2022.102470","article-title":"Explainable artificial intelligence (XAI) in deep learning-based medical image analysis","volume":"79","author":"van der Velden","year":"2022","journal-title":"Med Image Anal"},{"key":"10.1016\/j.ajps.2026.101144_bib0142","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.csbj.2024.08.005","article-title":"Unveiling the black box: a systematic review of explainable artificial intelligence in medical image analysis","volume":"24","author":"Muhammad","year":"2024","journal-title":"Comput Struct Biotechnol J"},{"issue":"11","key":"10.1016\/j.ajps.2026.101144_bib0143","doi-asserted-by":"crossref","first-page":"e745","DOI":"10.1016\/S2589-7500(21)00208-9","article-title":"The false hope of current approaches to explainable artificial intelligence in health care","volume":"3","author":"Ghassemi","year":"2021","journal-title":"Lancet Digit Health"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0144","doi-asserted-by":"crossref","first-page":"354","DOI":"10.15441\/ceem.23.145","article-title":"Explainable artificial intelligence in emergency medicine: an overview","volume":"10","author":"Okada","year":"2023","journal-title":"Clin Exp Emerg Med"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/bioengineering10020261","article-title":"Immunosensing for early detection of rheumatoid arthritis biomarkers: anti-cyclic citrullinated peptide antibodies based on tilted-fiber Bragg grating biosensor","volume":"10","author":"Wen","year":"2023","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.ajps.2026.101144_bib0146","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-0716-0138-9_7","article-title":"Electrochemical detection of dsDNA-specific antibodies","volume":"2063","author":"Fagundez","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"Pt 3","key":"10.1016\/j.ajps.2026.101144_bib0147","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/brain\/awn009","article-title":"Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement","volume":"131","author":"Vellinga","year":"2008","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.ajps.2026.101144_bib0148","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/ndt\/gfv128","article-title":"miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis","volume":"30","author":"Sole","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"23","key":"10.1016\/j.ajps.2026.101144_bib0149","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.7150\/thno.47601","article-title":"Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"issue":"37","key":"10.1016\/j.ajps.2026.101144_bib0150","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003399","article-title":"Tocilizumab-conjugated polymer nanoparticles for NIR-II photoacoustic-imaging-guided therapy of rheumatoid arthritis","volume":"32","author":"Chen","year":"2020","journal-title":"Adv Mater"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0151","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11481-020-09931-w","article-title":"T cell delivery of nanoparticles-bound anti-CD20 monoclonal antibody: successful B cell depletion in the spinal cord during experimental autoimmune encephalomyelitis","volume":"16","author":"Carnasciali","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0152","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar3089","article-title":"Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis","volume":"12","author":"Anderson","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0153","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ijpharm.2011.03.025","article-title":"Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis","volume":"416","author":"van den Hoven","year":"2011","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0154","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.expneurol.2008.02.005","article-title":"Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: long-term protective effects and enhanced efficacy of methylprednisolone formulations","volume":"211","author":"Linker","year":"2008","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12967-022-03267-0","article-title":"Methotrexate-loaded nanoparticles ameliorate experimental model of autoimmune arthritis by regulating the balance of interleukin-17-producing T cells and regulatory T cells","volume":"20","author":"Park","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajps.2026.101144_bib0156","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fimmu.2018.00230","article-title":"Nanoparticles for the induction of antigen-specific immunological tolerance","volume":"9","author":"Kishimoto","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2026.101144_bib0157","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103125","article-title":"Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease","volume":"140","author":"Kishimoto","year":"2023","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0158","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1172\/JCI69187","article-title":"Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis","volume":"123","author":"Macauley","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajps.2026.101144_bib0159","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40360-015-0022-0","article-title":"Effect of PEGylated phosphatidylserine-containing liposomes in experimental chronic arthritis","volume":"16","author":"Urbano","year":"2015","journal-title":"BMC Pharmacol Toxicol"},{"issue":"6478","key":"10.1016\/j.ajps.2026.101144_bib0160","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0161","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/ijms22031144","article-title":"Therapeutic application of exosomes in inflammatory diseases","volume":"22","author":"Suh","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"Pt B","key":"10.1016\/j.ajps.2026.101144_bib0162","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jconrel.2015.07.019","article-title":"Cell membrane-camouflaged nanoparticles for drug delivery","volume":"220","author":"Luk","year":"2015","journal-title":"J Control Release"},{"issue":"23","key":"10.1016\/j.ajps.2026.101144_bib0163","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101144_bib0164","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.26316","article-title":"Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting","volume":"4","author":"Wiklander","year":"2015","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0165","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12085","article-title":"Biodistribution of extracellular vesicles following administration into animals: a systematic review","volume":"10","author":"Kang","year":"2021","journal-title":"J Extracell Vesicles"},{"issue":"27","key":"10.1016\/j.ajps.2026.101144_bib0166","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.ajps.2026.101144_bib0167","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41565-018-0254-4","article-title":"Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis","volume":"13","author":"Zhang","year":"2018","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.ajps.2026.101144_bib0168","first-page":"1","article-title":"Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment","volume":"18","author":"Zhang","year":"2022","journal-title":"Bioact Mater"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0169","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13287-024-03834-w","article-title":"Mesenchymal stem cells-derived extracellular vesicles ameliorate lupus nephritis by regulating T and B cell responses","volume":"15","author":"Li","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0170","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1080\/08820139.2022.2055478","article-title":"Mesenchymal stem cells-derived exosomes ameliorate lupus by inducing M2 macrophage polarization and regulatory T cell expansion in MRL\/lpr mice","volume":"51","author":"Sun","year":"2022","journal-title":"Immunol Invest"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0171","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1038\/s41467-021-26052-x","article-title":"Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0172","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","article-title":"Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles","volume":"172","author":"Kooijmans","year":"2013","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.ajps.2026.101144_bib0173","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/cells12101416","article-title":"Current strategies for exosome cargo loading and targeting delivery","volume":"12","author":"Zeng","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0174","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","article-title":"Recent advances in extracellular vesicles for therapeutic cargo delivery","volume":"56","author":"Kim","year":"2024","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12951-023-01773-x","article-title":"Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis","volume":"21","author":"Yang","year":"2023","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0176","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.ajps.2026.101144_bib0177","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3389\/fbioe.2020.00627","article-title":"Cell membrane-based biomimetic nanoparticles and the immune system: immunomodulatory interactions to therapeutic applications","volume":"8","author":"Sushnitha","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.ajps.2026.101144_bib0178","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.772522","article-title":"Research progress on cell membrane-coated biomimetic delivery systems","volume":"9","author":"Guo","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0179","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3390\/ijms25042071","article-title":"Cell membrane-coated nanoparticles for precision medicine: a comprehensive review of coating techniques for tissue-specific therapeutics","volume":"25","author":"Fernandez-Borbolla","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0180","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/s40001-024-02124-8","article-title":"Application of targeted drug delivery by cell membrane-based biomimetic nanoparticles for inflammatory diseases and cancers","volume":"29","author":"Qiu","year":"2024","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0181","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Thery","year":"2018","journal-title":"J Extracell Vesicles"},{"issue":"24","key":"10.1016\/j.ajps.2026.101144_bib0182","doi-asserted-by":"crossref","first-page":"24696","DOI":"10.1021\/acsnano.3c04497","article-title":"ROS-scavenging lignin-based tolerogenic nanoparticle vaccine for treatment of multiple sclerosis","volume":"17","author":"Phan","year":"2023","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0183","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4049\/jimmunol.2200208","article-title":"Tolerogenic immune-modifying nanoparticles encapsulating multiple recombinant pancreatic beta cell proteins prevent onset and progression of type 1 diabetes in nonobese diabetic mice","volume":"209","author":"Podojil","year":"2022","journal-title":"J Immunol"},{"issue":"43","key":"10.1016\/j.ajps.2026.101144_bib0184","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1016\/j.vaccine.2014.08.016","article-title":"Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis","volume":"32","author":"Cappellano","year":"2014","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.ajps.2026.101144_bib0185","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp Mol Med"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0186","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101144_bib0187","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.addr.2017.04.005","article-title":"In vivo reprogramming of immune cells: technologies for induction of antigen-specific tolerance","volume":"114","author":"Pearson","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"10.1016\/j.ajps.2026.101144_bib0188","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41577-023-00970-x","article-title":"Therapeutic induction of antigen-specific immune tolerance","volume":"24","author":"Kenison","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0189","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/0192623320948805","article-title":"Opinion on immune tolerance therapeutic development","volume":"48","author":"Radi","year":"2020","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.ajps.2026.101144_bib0190","first-page":"95","article-title":"Gold nanoparticles-embedded ceria with enhanced antioxidant activities for treating inflammatory bowel disease","volume":"25","author":"Li","year":"2023","journal-title":"Bioact Mater"},{"issue":"31","key":"10.1016\/j.ajps.2026.101144_bib0191","doi-asserted-by":"crossref","first-page":"26108","DOI":"10.1021\/acsami.8b10345","article-title":"Prussian blue nanozyme with multienzyme activity reduces colitis in mice","volume":"10","author":"Zhao","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0192","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1039\/D1BM01525G","article-title":"Reactive oxygen species-scavenging hollow MnO2 nanozymes as carriers to deliver budesonide for synergistic inflammatory bowel disease therapy","volume":"10","author":"Qiu","year":"2022","journal-title":"Biomater Sci"},{"issue":"10","key":"10.1016\/j.ajps.2026.101144_bib0193","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.7150\/thno.33727","article-title":"Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease","volume":"9","author":"Zhao","year":"2019","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.ajps.2026.101144_bib0194","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nmat2859","article-title":"Orally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestines","volume":"9","author":"Wilson","year":"2010","journal-title":"Nat Mater"},{"key":"10.1016\/j.ajps.2026.101144_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114205","article-title":"Antibacterial hyaluronic acid hydrogel with sustained release of larazotide as effective colitis treatment","volume":"387","author":"Yu","year":"2025","journal-title":"J Control Release"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0196","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/gutjnl-2022-328387","article-title":"Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis","volume":"72","author":"Wagner","year":"2023","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0197","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.cgh.2024.11.013","article-title":"A randomized phase II study of efmarodocokin alfa, an interleukin-22 agonist, versus vedolizumab in patients with ulcerative colitis","volume":"23","author":"Danese","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6109","key":"10.1016\/j.ajps.2026.101144_bib0198","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1126\/science.1226338","article-title":"Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities","volume":"338","author":"Cheng","year":"2012","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0199","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"Dordevic","year":"2022","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.ajps.2026.101144_bib0200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.copbio.2017.01.002","article-title":"Advances in the clinical translation of nanotechnology","volume":"46","author":"Scheinberg","year":"2017","journal-title":"Curr Opin Biotechnol"},{"issue":"12","key":"10.1016\/j.ajps.2026.101144_bib0201","doi-asserted-by":"crossref","first-page":"13620","DOI":"10.1021\/acsnano.9b08659","article-title":"Nanomedicines lost in translation","volume":"13","author":"Guidolin","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101144_bib0202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1743-8977-9-41","article-title":"Contamination of nanoparticles by endotoxin: evaluation of different test methods","volume":"9","author":"Smulders","year":"2012","journal-title":"Part Fibre Toxicol"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0203","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0204","article-title":"Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"issue":"15","key":"10.1016\/j.ajps.2026.101144_bib0205","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.addr.2012.07.005","article-title":"A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines","volume":"64","author":"Szebeni","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0206","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i6.50","article-title":"Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents","volume":"18","author":"Szebeni","year":"2001","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"5","key":"10.1016\/j.ajps.2026.101144_bib0207","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0208","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J Control Release"},{"issue":"1\u20132","key":"10.1016\/j.ajps.2026.101144_bib0209","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2007.11.005","article-title":"Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes","volume":"354","author":"Ishida","year":"2008","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0210","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci Technol Adv Mater"},{"issue":"9","key":"10.1016\/j.ajps.2026.101144_bib0211","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0212","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1073\/pnas.1401965111","article-title":"Genomic responses in mouse models greatly mimic human inflammatory diseases","volume":"112","author":"Takao","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0213","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/ard.2008.099291","article-title":"Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study","volume":"68","author":"Fleischmann","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0214","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1474-4422(14)70068-7","article-title":"PEGylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study","volume":"13","author":"Calabresi","year":"2014","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5301\/ejo.5000779","article-title":"Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial","volume":"26","author":"Leonardi","year":"2016","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0216","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2013.07.016","article-title":"A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjogren\u2019s syndrome","volume":"171","author":"Shah","year":"2013","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0217","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1021\/acsami.4c16595","article-title":"SHED-derived exosomes ameliorate Sjogren\u2019s syndrome-induced hyposalivation by suppressing Th1 cell response via the miR-29a-3p\/T-bet axis","volume":"17","author":"Du","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0218","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1021\/acsnano.4c15164","article-title":"Extracellular matrix-inspired dendrimer nanogels encapsulating cyclophosphamide for systemic sclerosis treatment","volume":"19","author":"Lu","year":"2025","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0219","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1186\/s12951-025-03725-z","article-title":"Manganese-loaded carbon nanoparticles ameliorate ANCA-associated vasculitis by inhibiting ferroptosis","volume":"23","author":"Wang","year":"2025","journal-title":"J Nanobiotechnol"},{"issue":"14","key":"10.1016\/j.ajps.2026.101144_bib0220","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1089\/ars.2012.4530","article-title":"Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets","volume":"19","author":"Biasi","year":"2013","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0221","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.48.4.571","article-title":"Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs","volume":"48","author":"Nugent","year":"2001","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0222","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1172\/JCI94549","article-title":"Autoreactive T cells in type 1 diabetes","volume":"127","author":"Pugliese","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0223","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1021\/acsabm.4c01708","article-title":"Facile synthesis of polymeric nanoprobes for actively targeted and high-performance MR\/CT dual-modal imaging of rheumatoid arthritis","volume":"8","author":"Chen","year":"2025","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.ajps.2026.101144_bib0224","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.2147\/IJN.S457004","article-title":"Microenvironmental enzyme-responsive methotrexate modified quercetin micelles for the treatment of rheumatoid arthritis","volume":"19","author":"Li","year":"2024","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0225","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s10020-024-00929-1","article-title":"Metabolic effects of quercetin on inflammatory and autoimmune responses in rheumatoid arthritis are mediated through the inhibition of JAK1\/STAT3\/HIF-1alpha signaling","volume":"30","author":"Zhang","year":"2024","journal-title":"Mol Med"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0226","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/antib12040069","article-title":"When autoantibodies are missing: the challenge of seronegative rheumatoid arthritis","volume":"12","author":"Paroli","year":"2023","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.ajps.2026.101144_bib0227","article-title":"Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: a critical review","volume":"10","author":"Stainer","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0228","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s40620-020-00832-y","article-title":"Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis","volume":"34","author":"Perez-Hernandez","year":"2021","journal-title":"J Nephrol"},{"key":"10.1016\/j.ajps.2026.101144_bib0229","article-title":"Urinary exosome tsRNAs as novel markers for diagnosis and prediction of lupus nephritis","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ajps.2026.101144_bib0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138618","article-title":"Increased urinary exosomal MicroRNAs in patients with systemic lupus erythematosus","volume":"10","author":"Perez-Hernandez","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0231","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s13287-022-03174-7","article-title":"Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17+ regulatory T cell","volume":"13","author":"Zhang","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0232","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/biom11070928","article-title":"Clinical and immunological biomarkers for systemic lupus erythematosus","volume":"11","author":"Yu","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ajps.2026.101144_bib0233","article-title":"Advanced methods and novel biomarkers in autoimmune diseases \u2011 a review of the recent years progress in systemic lupus erythematosus","volume":"10","author":"Fenton","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0234","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Kariko","year":"2005","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.ajps.2026.101144_bib0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ajps.2026.101144_bib0236","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-065X.1998.tb01208.x","article-title":"The functional significance of epitope spreading and its regulation by co-stimulatory molecules","volume":"164","author":"Vanderlugt","year":"1998","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0237","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0952-7915(96)80012-4","article-title":"Epitope spreading","volume":"8","author":"Vanderlugt","year":"1996","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"10.1016\/j.ajps.2026.101144_bib0238","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028928","article-title":"Clinical course of multiple sclerosis","volume":"8","author":"Klineova","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0239","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40120-020-00202-7","article-title":"State of the art and future challenges in multiple sclerosis research and medical management: an insight into the 5th International Porto Congress of Multiple Sclerosis","volume":"9","author":"Sa","year":"2020","journal-title":"Neurol Ther"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12951-024-02434-3","article-title":"Attenuation of inflammatory bowel disease by oral administration of mucoadhesive polydopamine-coated yeast beta-glucan via ROS scavenging and gut microbiota regulation","volume":"22","author":"Yang","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.ajps.2026.101144_bib0241","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/IJN.S442761","article-title":"Combined ROS responsive polydopamine-coated berberine nanoparticles effective against ulcerative colitis in mouse model","volume":"19","author":"Chang","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ajps.2026.101144_bib0242","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.actbio.2023.02.026","article-title":"ROS scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease","volume":"161","author":"Bao","year":"2023","journal-title":"Acta Biomater"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0243","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41565-023-01346-x","article-title":"Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis","volume":"18","author":"Cao","year":"2023","journal-title":"Nat Nanotechnol"},{"issue":"16","key":"10.1016\/j.ajps.2026.101144_bib0244","doi-asserted-by":"crossref","first-page":"15893","DOI":"10.1021\/acsnano.3c03959","article-title":"Capsulated cellular nanosponges for the treatment of experimental inflammatory bowel disease","volume":"17","author":"Duan","year":"2023","journal-title":"ACS Nano"},{"issue":"23","key":"10.1016\/j.ajps.2026.101144_bib0245","doi-asserted-by":"crossref","first-page":"24404","DOI":"10.1021\/acsnano.3c11089","article-title":"Orally administrated inflamed colon-targeted nanotherapeutics for inflammatory bowel disease treatment by oxidative stress level modulation in colitis","volume":"17","author":"Min","year":"2023","journal-title":"ACS Nano"},{"issue":"19","key":"10.1016\/j.ajps.2026.101144_bib0246","doi-asserted-by":"crossref","first-page":"18965","DOI":"10.1021\/acsnano.3c04569","article-title":"Nanocrystalline cellulose modulates dysregulated intestinal barriers in ulcerative colitis","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0247","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/diagnostics10060367","article-title":"Biochemical biomarkers of mucosal healing for inflammatory bowel disease in adults","volume":"10","author":"Krzystek-Korpacka","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"13","key":"10.1016\/j.ajps.2026.101144_bib0248","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.3390\/ijms23136966","article-title":"Inflammatory bowel disease treatments and predictive biomarkers of therapeutic response","volume":"23","author":"Elhag","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101144_bib0249","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1089262","article-title":"Advances in pathogenesis and nanoparticles (NPs)-mediated treatment of psoriasis","volume":"13","author":"Shen","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ajps.2026.101144_bib0250","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1021\/acsnano.2c07843","article-title":"Hyaluronic acid nanoparticles as a topical agent for treating psoriasis","volume":"16","author":"Lee","year":"2022","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0251","first-page":"268","article-title":"Alantolactone-loaded chitosan\/hyaluronic acid nanoparticles suppress psoriasis by deactivating STAT3 pathway and restricting immune cell recruitment","volume":"17","author":"Chen","year":"2022","journal-title":"Asian J Pharm Sci"},{"issue":"40","key":"10.1016\/j.ajps.2026.101144_bib0252","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202300812","article-title":"Nanotargeted delivery of immune therapeutics in type 1 diabetes","volume":"35","author":"Jung","year":"2023","journal-title":"Adv Mater"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0253","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2025.100020","article-title":"Hyperthermia-enhanced immunoregulation hydrogel for oxygenation and ROS neutralization in diabetic foot ulcers","volume":"1","author":"Qi","year":"2025","journal-title":"Cell Biomaterials"},{"issue":"9","key":"10.1016\/j.ajps.2026.101144_bib0254","doi-asserted-by":"crossref","first-page":"11144","DOI":"10.1021\/acsami.1c25014","article-title":"Dendritic hydrogels with robust inherent antibacterial properties for promoting bacteria-infected wound healing","volume":"14","author":"Cheng","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2026.101144_bib0255","first-page":"562","article-title":"A cuttlefish ink nanoparticle-reinforced biopolymer hydrogel with robust adhesive and immunomodulatory features for treating oral ulcers in diabetes","volume":"39","author":"Xiang","year":"2024","journal-title":"Bioact Mater"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0256","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/pharmaceutics14030644","article-title":"Nanotechnology in immunotherapy for type 1 diabetes: promising innovations and future advances","volume":"14","author":"Nigam","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0257","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/nano10020190","article-title":"Immunological and toxicological considerations for the design of liposomes","volume":"10","author":"Inglut","year":"2020","journal-title":"Nanomaterials (Basel)"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0258","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nnano.2009.175","article-title":"Evaluation of nanoparticle immunotoxicity","volume":"4","author":"Dobrovolskaia","year":"2009","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0259","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/ijms22010385","article-title":"Safe nanoparticles: are we there yet?","volume":"22","author":"Najahi-Missaoui","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101144_bib0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115115","article-title":"Silica nanoparticles: a review of their safety and current strategies to overcome biological barriers","volume":"203","author":"Janjua","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2026.101144_bib0261","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.26901","article-title":"Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day","volume":"4","author":"Gardiner","year":"2015","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0262","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.ajps.2026.101144_bib0263","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2023.11.006","article-title":"Activation of the complement system by nanoparticles and strategies for complement inhibition","volume":"193","author":"Haroon","year":"2023","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ajps.2026.101144_bib0264","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.17807","article-title":"An insight into impact of nanomaterials toxicity on human health","volume":"12","author":"Qamar","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.ajps.2026.101144_bib0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114083","article-title":"Clinical translation of nanomedicines: challenges, opportunities, and keys","volume":"181","author":"Younis","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2026.101144_bib0266","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.02.017","article-title":"Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery","volume":"344","author":"Maeki","year":"2022","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.ajps.2026.101144_bib0267","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nri3311","article-title":"Humanized mice for immune system investigation: progress, promise and challenges","volume":"12","author":"Shultz","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajps.2026.101144_bib0268","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","article-title":"Humanized mouse models of clinical disease","volume":"12","author":"Walsh","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ajps.2026.101144_bib0269","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fimmu.2019.00203","article-title":"Humanized mouse models of rheumatoid arthritis for studies on immunopathogenesis and preclinical testing of cell-based therapies","volume":"10","author":"Schinnerling","year":"2019","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0270","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat Rev Genet"},{"issue":"8","key":"10.1016\/j.ajps.2026.101144_bib0271","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.tibtech.2020.01.003","article-title":"Engineering microphysiological immune system responses on chips","volume":"38","author":"Miller","year":"2020","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.ajps.2026.101144_bib0272","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1373186","article-title":"In vitro immunity: an overview of immunocompetent organ-on-chip models","volume":"15","author":"Morrison","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2026.101144_bib0273","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67106","article-title":"Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies","volume":"10","author":"Kerns","year":"2021","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0274","doi-asserted-by":"crossref","DOI":"10.1063\/5.0179444","article-title":"Microphysiological systems as reliable drug discovery and evaluation tools: evolution from innovation to maturity","volume":"17","author":"Moon","year":"2023","journal-title":"Biomicrofluidics"},{"issue":"25","key":"10.1016\/j.ajps.2026.101144_bib0275","article-title":"Endogenous melanin and hydrogen-based specific activated theranostics nanoagents: a novel multi-treatment paradigm for rheumatoid arthritis","volume":"11","author":"Chen","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.ajps.2026.101144_bib0276","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2023.07.040","article-title":"An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice","volume":"361","author":"Chou","year":"2023","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.ajps.2026.101144_bib0277","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jacep.2023.10.024","article-title":"Toward digital twin technology for precision pharmacology","volume":"10","author":"Yang","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"issue":"11","key":"10.1016\/j.ajps.2026.101144_bib0278","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1021\/acs.molpharmaceut.5c00661","article-title":"Machine learning analysis of cytotoxicity determinants in nanoparticle-based rheumatoid arthritis therapies","volume":"22","author":"Yildirim","year":"2025","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0279","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13073-024-01314-7","article-title":"scDrugPrio: a framework for the analysis of single-cell transcriptomics to address multiple problems in precision medicine in immune-mediated inflammatory diseases","volume":"16","author":"Schafer","year":"2024","journal-title":"Genome Med"},{"key":"10.1016\/j.ajps.2026.101144_bib0280","article-title":"Effectiveness of sentinel lymph node biopsy and bilateral pelvic nodal dissection using methylene blue dye in early-stage operable cervical cancer-a prospective study","volume":"39","author":"Vemula Venkata","year":"2024","journal-title":"Cancer Treat Res Commun"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0281","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41571-020-00460-2","article-title":"Advances in the development of personalized neoantigen-based therapeutic cancer vaccines","volume":"18","author":"Blass","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.ajps.2026.101144_bib0282","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem Rev"},{"key":"10.1016\/j.ajps.2026.101144_bib0283","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-4939-1115-8_17","article-title":"Classification of human leukocyte antigen (HLA) supertypes","volume":"1184","author":"Wang","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ajps.2026.101144_bib0284","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0285","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-001078","article-title":"Potential involvement of circulating exosomal miRNA-146a in disease activity and TRAF6 gene expression in juvenile proliferative lupus nephritis","volume":"11","author":"Somparn","year":"2024","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ajps.2026.101144_bib0286","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115793","article-title":"Development of an impedance-based biosensor for determination of IgG galactosylation levels","volume":"245","author":"Khorshed","year":"2024","journal-title":"Biosens Bioelectron"},{"issue":"3","key":"10.1016\/j.ajps.2026.101144_bib0287","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/vaccines11030687","article-title":"Exosomes as rheumatoid arthritis diagnostic biomarkers and therapeutic agents","volume":"11","author":"Heydari","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ajps.2026.101144_bib0288","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-0716-3346-5_16","article-title":"Role of liquid biopsies in rheumatoid arthritis","volume":"2695","author":"Bo","year":"2023","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ajps.2026.101144_bib0289","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.343493","article-title":"A portable optical detection system for rapid quantification of two rheumatoid arthritis biomarkers","volume":"1336","author":"Chen","year":"2025","journal-title":"Anal Chim Acta"},{"issue":"11","key":"10.1016\/j.ajps.2026.101144_bib0290","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/bios14110545","article-title":"Rapid microfluidic biosensor for point-of-care determination of rheumatoid arthritis via anti-cyclic citrullinated peptide antibody detection","volume":"14","author":"Tai","year":"2024","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.ajps.2026.101144_bib0291","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116414","article-title":"Diagnosis of neuropsychiatric systemic lupus erythematosus by label-free serum microsphere-coupled SERS fingerprints with machine learning","volume":"260","author":"Mi","year":"2024","journal-title":"Biosens Bioelectron"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0292","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0306999","article-title":"Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors","volume":"19","author":"Campanioni","year":"2024","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ajps.2026.101144_bib0293","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2024.08.015","article-title":"Predicting tissue distribution and tumor delivery of nanoparticles in mice using machine learning models","volume":"374","author":"Mi","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101144_bib0294","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jconrel.2023.02.038","article-title":"Application of magnetic particle imaging to evaluate nanoparticle fate in rodent joints","volume":"356","author":"Ajayi","year":"2023","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.ajps.2026.101144_bib0295","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41746-024-01073-0","article-title":"Digital twins for health: a scoping review","volume":"7","author":"Katsoulakis","year":"2024","journal-title":"NPJ Digit Med"},{"issue":"7","key":"10.1016\/j.ajps.2026.101144_bib0296","article-title":"A deep learning system for detecting systemic lupus erythematosus from retinal images","volume":"6","author":"Li","year":"2025","journal-title":"Cell Rep Med"},{"issue":"Pt 1","key":"10.1016\/j.ajps.2026.101144_bib0297","article-title":"Thermally-responsive and reduced glutathione-sensitive folate-targeted nanocarrier based on alginate and pluronic F127 for on-demand release of methotrexate","volume":"263","author":"Dang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ajps.2026.101144_bib0298","article-title":"Hyaluronic acid-anchored nanoparticles co-delivering emodin and siRNA confers protection against rheumatoid arthritis via macrophage polarization","volume":"33","author":"Qin","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.ajps.2026.101144_bib0299","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jconrel.2021.12.007","article-title":"Intravenous PEGylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: a randomized controlled clinical trial","volume":"341","author":"Metselaar","year":"2022","journal-title":"J Control Release"},{"issue":"20","key":"10.1016\/j.ajps.2026.101144_bib0300","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160964","article-title":"Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide\/calcitriol liposomes in ACPA+ rheumatoid arthritis","volume":"7","author":"Sonigra","year":"2022","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.ajps.2026.101144_bib0301","doi-asserted-by":"crossref","first-page":"8313","DOI":"10.3390\/ijms24098313","article-title":"Immunosuppressive polymeric nanoparticles targeting dendritic cells alleviate lupus disease in Fcgr2b-\/- mice by mediating antigen-specific immune tolerance","volume":"24","author":"Khiewkamrop","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101144_bib0302","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nano.2018.10.001","article-title":"Overcoming challenges in treating autoimmuntity: development of tolerogenic immune-modifying nanoparticles","volume":"18","author":"Pearson","year":"2019","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.ajps.2026.101144_bib0303","doi-asserted-by":"crossref","first-page":"eabj2372","DOI":"10.1126\/sciadv.abj2372","article-title":"A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease","volume":"8","author":"Shi","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.ajps.2026.101144_bib0304","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.2147\/IJN.S247007","article-title":"Methotrexate-loaded nanostructured lipid carrier gel alleviates imiquimod-induced psoriasis by moderating inflammation: formulation, optimization, characterization, in-vitro and in-vivo studies","volume":"15","author":"Agrawal","year":"2020","journal-title":"Int J Nanomedicine"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087626000309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087626000309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:00:33Z","timestamp":1778907633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087626000309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":304,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1818087626000309"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2026.101144","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in nanotechnology for the diagnosis and management of autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2026.101144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101144"}}